Literature

SureSeq myPanel™ NGS Custom AML Panels

Type: Product profile

Comparison of CytoSure™ Constitutional NGS with Microarrays for CNV detection

This technical note compares performance of CytoSure Constitutional NGS and a range of microarrays for 255 research samples processed in three independent laboratories and OGT.

Type: Application note

Interpret NGS Analysis Software

Type: Product profile

A next generation sequencing solution to detect copy number variants, single nucleotide variants and loss of heterozygosity in intellectual disability and developmental delay samples

Presented at ESHG Virtual 2020, this poster outlines the results from over 200 intellectual disability and developmental research samples to demonstrate the efficiency of the CNV, SNV and LOH detection.

Type: Poster

CytoSure™ Array Handbook (4x44k and 4x180k formats)

Type: Handbook

CytoSure™ Array Handbook (8x15k and 8x60k formats)

Type: Handbook

CytoSure™ HT Array Handbook (8x15k and 8x60k formats)

Type: Handbook

A New Next Generation Sequencing (NGS) Assay for Detecting the Aberrations in Intellectual Disability and Developmental Delay Samples

Presented at ACMG 2020, this poster demonstrates the capability of a novel NGS assay designed to analyse genetic aberrations, including CNVs, SNVs, Indels and LOH, in intellectual disability and developmental delay research samples.

Type: Poster

SureSeq™ Core MPN Panel

Type: Product profile

Interpret Quick-Start Guide

Download OGT's Interpret NGS analysis software quick-start guide, for use with SureSeq™ and CytoSure™ NGS panels.

Type: Guide

Oxford Gene Technology Expands NGS Offering Into Constitutional Cytogenetics

Oxford Gene Technology recently rolled out its first next-generation sequencing product for constitutional cytogenetics research. The company believes cytogeneticists will adopt its panel to get high-quality single nucleotide variant (SNV) and copy number

Type: Article

CytoSure™ NGS Library Preparation - Instructions for Use

Read and download instructions for use for the CytoSure NGS Library Preparation.

Type: Handbook

Clearance of ctDNA in triple negative and Her2 positive breast cancer patients during neoadjuvant treatment is correlated with pathological complete responses

The primary objective of this study was to assess ctDNA clearance during neoadjuvant treatment as a correlate to effective response to treatment, as benchmarked by clinical complete response (cCR) and pathological complete response (pCR).

Type: Poster

NGS Custom Cancer Panels Overview

Discover the wide range of cancers SureSeq myPanel's pre-optimised NGS custom panel content is available for.

Type: Guide